Skip to content

Transform your optic center in a specialized dry eye practice.

Screening
me-check®

me-check®

Accessible, Simple, Unique

We believe screening for dry eye disease shouldn’t be hard, nor expensive, for both operators and people.

me-check® is the ultimate solution to screen for dry eye. It’s the only certified device for use in optic centers, and it’s been developed to be effective, providing consistent results in just 5 minutes.

Benefits

Our me-check® screening solution offers great benefits:

  • ① it’s fast—it takes 5’
  • ② it’s non-invasive
  • ③ it’s intuitive
  • ④ it’s repeatable+consistent
  • ⑤ it’s modular+integrated
Treatment
my-mask®

my-mask®

Exceptional
Results

Originally developed by NASA, the Light Modulation® Low-level Light Therapy technology has been developed and certified to manage dry eye disease in the long term.

The photobiostimulation of LM® LLLT technology built into my-mask® is completely non-invasive, yet granting exceptional results.

Benefits

LM® LLLT technology has many unique benefits:

  • ① it’s fast—a session lasts 15’
  • ② it’s non-invasive
  • ③ it grants immediate relief
  • ④ it’s safe for the client
  • ⑤ it’s easy for the operator

Introducing Light Modulation® Low-level Light Therapy—a radically different technology.

The degree of simplicity offered by LM® LLLT technology to the operator, and the convenience hence provided to the patient benefitting from its therapy is, put simply, unmatched. This, paired with LM® LLLT's exceptional efficacy in treating Dry Eye Disease (DED) related to Meibomian Glands Dysfunction (MGD), makes it a true game-changer.

"A weekly protocol of serial sessions with a newly developed LLLT mask for home use allowed the significant improvement of the main objective parameters of the ocular surface (both tear production and stability) along with the signif- icant amelioration of ocular discomfort symp- toms. These results are consistent with those obtained with the in-office LLLT device and open up a new scenario for patients with MGD who can enjoy the unique benefits of this technology at home.”

GIANNACCARE, Giuseppe et al. “Serial Sessions of a Novel Low-Level Light Therapy Device for Home Treatment of Dry Eye Disease.” Ophthalmology and therapy, 10.1007/s40123-022-00619-3. 9 Dec. 2022

Improve your dioptric calculations, manage dry eye disease and contact lens discomfort at best.

Download our brochure and get in touch to learn more!

Get in Touch to Get an Exclusive Quote

I want to be updated about Espansione products and services

This field is required.
This field is required.
This field is required.
A valid email address is required.
This field is required.
This field is required.
Select your role (Ophthalmology/Optometry)*
Select your role (Dermatology/Aesthetics)*
Sub-Specialty*
Sub-Specialty*
Other Specialty*
This field is required.
This field is required.
I have read the privacy policy and the terms and conditions of the site
This field is required.
I want to be updated about Espansione products and services. You can unsubscribe at any time, by using the “unsubscribe” feature at the bottom of any communication you receive.

Thank you for contacting us.

In compliance with current regulations, let us know which audience you belong to:

You must fill in the form to download the file.

I want to be updated about Espansione products and services

This field is required.
This field is required.
This field is required.
A valid email address is required.
This field is required.
This field is required.
Select your role (Ophthalmology/Optometry)*
Select your role (Dermatology/Aesthetics)*
Sub-Specialty*
Sub-Specialty*
Other Specialty*
This field is required.
This field is required.
I have read the privacy policy and the terms and conditions of the site
This field is required.
I want to be updated about Espansione products and services. You can unsubscribe at any time, by using the “unsubscribe” feature at the bottom of any communication you receive.

Thank you for contacting us.